Milton Keynes University Hospital is a district general hospital serving Milton Keynes, its borough and the surrounding area of north Buckinghamshire, south Northamptonshire and north-west Bedfordshire. It is located in the Eaglestone neighbourhood, and opened in 1984.

There are 500 beds in Milton Keynes University Hospital.

During the past decade, Milton Keynes University Hospital conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 2 clinical trials were completed, i.e. on average, 8.7% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 2 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Milton Keynes University Hospital" #1 sponsor was "Institute of Cancer Research, United Kingdom" with 3 trials, followed by "University College, London" with 3 trials sponsored, "University of Oxford" with 3 trials sponsored, "Judith Dixon-Hughes" with 2 trials sponsored and "Lymphoma Trials Office" with 2 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Milton Keynes University Hospital" #1 collaborator was "Cancer Research UK" with 2 trials as a collaborator, "NHS Greater Glasgow and Clyde" with 2 trials as a collaborator, "Oxford University Hospitals NHS Trust" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Australian and New Zealand Intensive Care Society Clinical Trials Group" with 1 trials as a collaborator. Other collaborators include 17 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "Milton Keynes University Hospital" are "Breast Cancer" (3 trials), "Prostate Cancer" (3 trials), "Colorectal Cancer" (2 trials), "Lung Cancer" (2 trials) and "Neoplasms Pancreatic" (2 trials). Many other conditions were trialed in "Milton Keynes University Hospital" in a lesser frequency.

Most popular intervention types in "Milton Keynes University Hospital" are "Drug" (19 trials), "Other" (5 trials), "Procedure" (4 trials), "Device" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Idelalisib" (2 trials), "Rituximab" (2 trials), "adjuvant therapy" (2 trials), "carboplatin" (2 trials) and "laboratory biomarker analysis" (2 trials). Other intervention names were less common.

The vast majority of trials in "Milton Keynes University Hospital" are 28 trials for "All" genders, 5 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Milton Keynes University Hospital". undefined are not yet recruiting, 12 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Milton Keynes University Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Milton Keynes University Hospital, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 7 trials that are defined as “Not Applicable".